Skip to content

Traversalgo

Active Private limited companyfounded 2011active for 15 yearsJean Tombeurstraat 19, 3090 OverijseKBO/BCE: BE 0841.104.915

Lifetime

15 annual accounts with figures on one time axis
peak of €247,825 in 2025
€247,825▲ 5.6%
peak of €129,455 in 2011
€121,561▲ 10.6%
peak of €714,003 in 2024
€425,673▼ 40.4%
€530,546▲ 234%
Board1 name since 2011
1 director
Documentsfilings and deeds
07-10-202668 days late
2025micro format
Dividend €409,892Equity from €714,003 to €425,673Debts from €158,684 to €530,546Cash from €151,238 to €209,744

Key points

from the 2025 annual accounts

Equity

€425,673 ▼ 40.4%
714,0032024+121,561Profit-409,892Dividend425,6732025

Traversalgo paid out €409,892 in dividends. That is 337% of the 2025 profit.

Turnover

≈ €460,000 estimated

The micro format states no turnover.

Debts

€530,546 ▲ 234%
Other debts
+377,079
Taxes and wages
+8,757
Suppliers
+231
The rest
-14,205

Debts rose by €371,862 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.

Liquidity

1.68 was 5.32 in 2024

Short-term debts rose from €141,784 to €521,436.

Filings

15 annual accounts 68 days
AprilJune31 JulyOctober201520202025

Latest accounts filed late: after the legal deadline.

Position in the sector

€956,218

Larger balance sheet than 86% of companies in human health. Sector median €277,522 · 21,347 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,815 companies had the same profile as Traversalgo has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,912 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,815 companies, not a prediction for Traversalgo. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 14-11-2011
  • deed of 12-01-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0841104915
Company renamed from Dr. , anesthesist to Traversalgo changes role from manager to director · “Het ter beschikking stellen van alle nodige middelen aan de artsen-aandeelhouders; Het inrichten van alle…” (deed in Dutch) · is a shareholder · Gazette deed
Capital decrease of €116,100 to €18,600 The capital fell from €134,700 to €18,600 · General meeting of 25-04-2018 · Gazette deed
Capital increase of €116,100 to €134,700 The capital rose from €18,600 to €134,700 · holds all the shares · General meeting of 19-02-2014 · Gazette deed
All 26 events

Comparable companies

same main activity, similar in size and age
Company
Traversalgo Overijse €1.0m €247,825 44.5% -
Dr Ponchon Overijse €1.0m €243,452 31.0% -
SOCIETE DE MEDECINE KADOU JOE Wezembeek-Oppem €0.9m €249,415 91.7% -
Dr. Johan Debeuf Rotselaar €1.0m €251,004 90.9% -
Dr. Sylvie GORDTS Leuven €0.9m €254,956 85.0% -
Orthodontie Hilde Joachum Lubbeek €1.0m €229,399 57.5% -
DR.NDJEKEMBO SHANGO DIDIER Wemmel €1.1m €235,659 64.1% -

These companies have the same main activity as Traversalgo: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €891,000 and €1.1m, founded between 2010 and 2013.

Official details

Source: KBO
Status
Active since 17-11-2011Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.303.539.2711800 Vilvoorde, since 14-11-2011
Financial year end
31 December
Peppol
Reachable since 03-01-2026
Company details

Annual accounts 2025

€956,218▲ 9.6%
Filing
Filed on 07-10-2026
Financials

Insights on Traversalgo

Traversalgo files the micro format. That format states no turnover. The gross margin rose from €211,160 in 2011 to €247,825 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Traversalgo

What is the company number of Traversalgo?
The company number of Traversalgo is 0841.104.915. The VAT number is the same number with BE in front: BE 0841.104.915.
Where is Traversalgo based?
The registered office is at Jean Tombeurstraat 19, 3090 Overijse.Company details
What does Traversalgo do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Traversalgo?
Traversalgo is a private limited company (BV).
When was Traversalgo founded?
Traversalgo was founded on 17-11-2011.
Is Traversalgo still active?
Yes, Traversalgo is an active enterprise in the KBO register.
What is the turnover of Traversalgo?
The turnover in financial year 2025 is ≈ €460,000. This figure is estimated from the gross margin of €247,825 and 40 comparable companies (NACE 86220). It probably lies between €390,000 and €610,000.Financials
Is Traversalgo profitable?
In financial year 2025, Traversalgo made a profit of €121,561.
Where can I find the annual accounts of Traversalgo?
Traversalgo filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Traversalgo due?
Traversalgo must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.